Andrew Wilkinson > Squire Patton Boggs > London, England > Lawyer Profile

Squire Patton Boggs’ ‘strong sense of commercialism and client-focused solutions based on a deep understanding of the sector’ allows the life sciences practice to excel in the pharmaceutical and medical device sectors, primarily focusing on regulatory and commercial issues. The group also regularly advises on product clearance, advertising and promotional matters, and the distinct healthcare team provides a range of advice to healthcare organisations. Commercial and IP specialist Andrew Wilkinson and healthcare experts Diarmuid Ryan and Mark Yeo jointly lead the group.

The communications, IP and technology group at Squire Patton Boggs is praised as a ‘very strong team‘. The group is well-versed in undertaking technology and telecoms transactions and M&A, as well as handling the regulatory and competition aspects of those transactions. Andrew Wilkinson is head of the firm’s IP and technology EMEA group and advises UK and international users of technology on a wide variety of matters, from cloud arrangements to system design, implementation and maintenance mandates. Francesco Liberatore leads the communication regulation group, and is notable for advising clients in the telecoms space. Senior associate James Pearson stands out for his expertise in technology contracts and the supply of IT, and Malcolm Dowden joined the group from Womble Bond Dickinson (UK) LLP in March 2022.